The introduction of Retatrutide ZPHC, at a dosage of 120mg, is generating considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 receptor medication seems to deliver impressive improvements in weight reduction compared to existing therapies. Early patient data